Danaher

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Danaher Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 15, 2023 – (NYSE: DHR)

Retrieved on: 
Friday, September 8, 2023
Danaher Corporation, NEXT, COVID-19, Danaher, Growth, Fraud, DHR, Holding company, Security (finance)

NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Danaher Corporation.

Key Points: 
  • NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Danaher Corporation.
  • Shareholders who purchased shares of DHR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
  • DEADLINE: September 15, 2023 Shareholders should not delay in registering for this class action.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

DANAHER DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Danaher Corporation and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, September 14, 2023
Class Action Lawsuit, Professional Services, Legal, Vaccine, P.C, Biotechnology, Telephone, COVID-19, Danaher, Jeanne Eagels (film), DHR, Research, Person, Danaher Corporation, Projection, District court, Cepheid variable, Biophysical environment, Court, Growth, NYSE, News, Pharmaceutical industry, Diagnosis

Investors have until September 15, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until September 15, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Danaher designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.
  • The Company is comprised of more than 20 operating companies organized under four segments: Biotechnology; Life Sciences; Diagnostics; and Environmental & Applied Solutions.
  • On April 25, 2023, Danaher issued a press release announcing its financial results for the first quarter of 2023.

Ingersoll Rand Names Santiago Arias Duval as Interim Leader for Global Precision & Science Technologies Business Segment

Retrieved on: 
Thursday, September 7, 2023
Machine Tools, Metalworking & Metallurgy, Engineering, Technology, Manufacturing, Other Technology, Other Manufacturing, Machinery, Vacuum, MIT Sloan School of Management, IR, Ingersoll Rand, Georgia Tech, Danaher, Fruit, PST, Business administration, Board on Science, Technology, and Economic Policy, Oberdorfer, MP, Master of Business Administration, NYSE, General Motors, Management, Science

Ingersoll Rand Inc. (NYSE: IR) today announced Santiago Arias Duval, vice president and general manager of Life Sciences, to serve as the interim business leader for the global Precision & Science Technologies (PST) business segment, effective immediately.

Key Points: 
  • Ingersoll Rand Inc. (NYSE: IR) today announced Santiago Arias Duval, vice president and general manager of Life Sciences, to serve as the interim business leader for the global Precision & Science Technologies (PST) business segment, effective immediately.
  • “Santiago has demonstrated deep industry knowledge, strategy execution, and technical expertise that can help propel the business forward.
  • We are confident he is the right person to lead PST during this transition.”
    Prior to Ingersoll Rand, Santiago held leadership roles at Danaher and General Motors.
  • Santiago holds a Bachelor of Science in electrical engineering from Georgia Institute of Technology and a Master of Business Administration from the MIT Sloan School of Management.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Thorne HealthTech, Inc. (Nasdaq - THRN), RPT Realty (NYSE - RPT), Abcam plc (Nasdaq - ABCM)

Retrieved on: 
Wednesday, September 6, 2023
Agreement, Tripura Merger Agreement, Brodsky, Kimco Realty, Danaher, DHR, Danaher Corporation, NYSE, KIM, RPT Realty, RPT, Security (finance), Abcam

BALA CYNWYD, Pa., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.

Key Points: 
  • BALA CYNWYD, Pa., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the Agreement, Thorne will be acquired by L Catterton for $10.20 per share in cash for each share of Thorne.
  • Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.

SHAREHOLDER ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 15, 2023 in the Class Action Filed on Behalf of Danaher Corporation (DHR) Shareholders

Retrieved on: 
Wednesday, September 6, 2023
Danaher Corporation, Telephone, COST, CLASS, COVID-19, Danaher, Growth, HOW, DHR, NYSE

NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Danaher Corporation (NYSE: DHR) alleging that the Company violated federal securities laws.

Key Points: 
  • NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Danaher Corporation (NYSE: DHR) alleging that the Company violated federal securities laws.
  • WHAT THIS MEANS TO YOU AS A SHAREHOLDER: If you have suffered a loss in Danaher you have until September 15, 2023 to petition the court for lead plaintiff status.
  • Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
  • HOW TO PROTECT YOUR FINANCIAL INTERESTS: For additional information about the DHR lawsuit, please contact J. Klein, Esq.

DANAHER CORPORATION (NYSE: DHR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Danaher Corporation

Retrieved on: 
Tuesday, September 5, 2023
LLP, Class, COVID-19, Danaher, DHR, Danaher Corporation, Projection, District court, Advertising, Complaint, Court, Growth, NYSE, News, Cryptocurrency, Security (finance), Pharmaceutical industry

Bernstein Liebhard LLP , a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Danaher Corporation (“Danaher” or the “Company”) (NYSE: DHR) between April 21, 2022 and April 24, 2023, inclusive (the “Class Period”).

Key Points: 
  • Bernstein Liebhard LLP , a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Danaher Corporation (“Danaher” or the “Company”) (NYSE: DHR) between April 21, 2022 and April 24, 2023, inclusive (the “Class Period”).
  • If you wish to serve as lead plaintiff, you must move the Court no later than September 15, 2023.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

ATLATL Beijing International Innovation Center Becomes Fully Operational

Retrieved on: 
Tuesday, September 5, 2023
Science, Other Science, Biotechnology, Research, Pharmaceutical, General Health, Health, Other Health, Acceleration, GMP, Drug development, Center for Cell and Gene Therapy, CGT, Charles River Laboratories, Gene, Bio 360 Life Sciences Park, Seed, Danaher, Zhongguancun, Government, Boehringer Ingelheim, Plant, Laboratory, Novo Nordisk, Miltenyi Biotec, Cell, Ecosystem, PCR, Creative industries, Pharmaceutical industry, Fine chemical

Phase II of the ATLATL Beijing International Innovation Center (referred to as "Beijing ATLATL"), located in the Zhongguancun Life Science Park, has officially commenced operations, marking the comprehensive launch of Beijing ATLATL.

Key Points: 
  • Phase II of the ATLATL Beijing International Innovation Center (referred to as "Beijing ATLATL"), located in the Zhongguancun Life Science Park, has officially commenced operations, marking the comprehensive launch of Beijing ATLATL.
  • Beijing ATLATL, initiated in 2021, has served more than 20 innovation teams, with total funding raised of more than 2 billion RMB.
  • Dr. PC Zhu, founder and CEO of ATLATL Innovation Center, stated that after more than two years in Beijing, ATLATL, leveraging its core R&D strength, has been vigorously constructing the Beijing ATLATL International Innovation Platform, pooling innovation and sourcing innovation.
  • Through sourcing and pooling innovation, ATLATL quickly connects China's biopharmaceutical innovation "seeds" with international resources, accelerates the development of "Life Valley" in Beijing, creates a globally leading innovation platform, and builds a world-class biopharmaceutical innovation cluster.

Lifshitz Law PLLC Announces Investigations of Rain Oncology, Inc. (NASDAQ: RAIN), Danaher Corp. (NYSE: DHR), Bausch Health Companies, Inc. (NYSE: BHC), and AT&T Inc. (NYSE: T)

Retrieved on: 
Sunday, September 3, 2023
AT&T, Telephone, RAIN, COVID-19, Danaher, Lead, BHC, MANTRA, DHR, Advertising, Growth, FDA, Hewlett, Safety, Pharmaceutical industry, Online shopping, Bausch

If you are a RAIN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.

Key Points: 
  • If you are a RAIN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.
  • If you are a DHR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.
  • The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780.
  • Prior results do not guarantee or predict a similar outcome with respect to any future matter.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Danaher Corporation of Class Action Lawsuit and Upcoming Deadline – DHR

Retrieved on: 
Friday, September 1, 2023
Vaccine, LLP, Biotechnology, COVID-19, Danaher, DHR, Research, Person, Danaher Corporation, Projection, Ext, SEC Rule 10b-5, District court, Action Replay, Complaint, Cepheid variable, Biophysical environment, Court, Growth, Pomerantz, NYSE, News, Pharmaceutical industry, Diagnosis

NEW YORK, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Danaher Corporation (“Danaher” or the “Company”) (NYSE: DHR), and certain officers.

Key Points: 
  • NEW YORK, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Danaher Corporation (“Danaher” or the “Company”) (NYSE: DHR), and certain officers.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

Danaher and Veralto to Webcast Investor and Analyst Meeting

Retrieved on: 
Thursday, August 31, 2023
Webcast, Danaher, DHR, NYSE, Cryptocurrency, Broadcasting, Danaher Corporation

WASHINGTON, Aug. 31, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) will host a live video webcast of Veralto's Investor and Analyst Meeting on September 6, 2023 beginning at approximately 12:00 p.m. CT.

Key Points: 
  • WASHINGTON, Aug. 31, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) will host a live video webcast of Veralto's Investor and Analyst Meeting on September 6, 2023 beginning at approximately 12:00 p.m. CT.
  • The event, which will provide a comprehensive overview of Veralto and its operating segments, will be held at Videojet's facility in Wood Dale, Illinois and hosted by Veralto President & CEO Jennifer L. Honeycutt.
  • A link to the webcast and accompanying slide presentation will be available on the "Investors" section of Danaher's website, www.danaher.com , under the subheading "Events & Presentations."
  • A replay of the video webcast will be available following the presentation.